Почетна › Немалоклетни карцином плућа › Nebraska › Lincoln
Kliničke studije za Немалоклетни карцином плућа u gradu Lincoln, NE
16 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Lincoln i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Тражи се учесникФаза 3
- Cancer Partners of Nebraska, Lincoln
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Тражи се учесникФаза 3
- NHO Revive Research Institute LLC ( Site 0118), Lincoln
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Cancer Partners of Nebraska, Lincoln
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Тражи се учесникФаза 3
- Nebraska Hematology-Oncology - Revive Research Institute LLC, Lincoln
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Тражи се учесникФаза 3
- Research Site, Lincoln
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Тражи се учесникФаза 3
- NHO Revive Research Institute, LLC ( Site 3218), Lincoln
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- NHO Revive Research Institute, Lincoln
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Nebraska Hematology-Oncology, Lincoln
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- USA14-0, Lincoln
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- Research Site, Lincoln
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Nebraska Hematology-Oncology /ID# 272970, Lincoln
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Тражи се учесникФаза 2
- Cancer Partners of Nebraska, Lincoln
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- NHO Revive Research Institute, LLC, Lincoln
- NHO Support Center, Lincoln
- Cancer Partners of Nebraska, Lincoln
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Тражи се учесникФаза 2/3
- Nho - Revive Research Institute /ID# 277569, Lincoln
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Research Site, Lincoln
Pan-tumor MRD Study
Тражи се учесникОпсервациона студија
- Cancer Partners of Nebraska, Lincoln
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Lincoln
- Затајење срца7 студија
- Рак плућа7 студија
- Коронарна болест срца5 студија
- Шизофренија4 студија
- Колоректални карцином4 студија
- Меланом3 студија
- Pneumokokne infekcije3 студија
- Многи мијелом3 студија
- Рак (све врсте)3 студија
- Рак дојке3 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.